Related references
Note: Only part of the references are listed.Heat shock protein expression independently predicts survival outcome in schistosomiasis-associated urinary bladder cancer
A. EL-Meghawry EL-Kenawy et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Expression of heat shock proteins in premalignant and malignant urothelial lesions of bovine urinary bladder
Mariarita Romanucci et al.
CELL STRESS & CHAPERONES (2012)
Small heat shock proteins in cancer therapy and prognosis
Amina Zoubeidi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells
Manabu Tatokoro et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Low-dose Hsp 90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy
Soichiro Yoshida et al.
CELL CYCLE (2011)
Stress Proteins and Cytokines are Urinary Biomarkers for Diagnosis and Staging of Bladder Cancer
David Margel et al.
EUROPEAN UROLOGY (2011)
Differential expression of HSPA1 and HSPA2 proteins in human tissues; tissue microarray-based immunohistochemical study
Dorota Scieglinska et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2011)
Clusterin Is a Critical Downstream Mediator of Stress-Induced YB-1 Transactivation in Prostate Cancer
Masaki Shiota et al.
MOLECULAR CANCER RESEARCH (2011)
Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma
Hongjie Li et al.
PROTEOME SCIENCE (2011)
Clusterin Immunoreactivity as a Predictive Factor for Progression of Non-Muscle-Invasive Bladder Carcinoma
Sinan Ekici et al.
UROLOGIA INTERNATIONALIS (2011)
17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells
Panagiotis K. Karkoulis et al.
BMC CANCER (2010)
Reactive Antibodies Against Bacillus Calmette-Guerin Heat-Shock Protein-65 Potentially Predict the Outcome of Immunotherapy for High-Grade Transitional Cell Carcinoma of the Bladder
Peter U. Ardelt et al.
CANCER (2010)
Hsp27 Promotes Insulin-Like Growth Factor-I Survival Signaling in Prostate Cancer via p90Rsk-Dependent Phosphorylation and Inactivation of BAD
Amina Zoubeidi et al.
CANCER RESEARCH (2010)
Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion
Manoj Garg et al.
EUROPEAN JOURNAL OF CANCER (2010)
Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
Kim N. Chi et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Serum and Tissue Profiling in Bladder Cancer Combining Protein and Tissue Arrays
Esteban Orenes-Pinero et al.
JOURNAL OF PROTEOME RESEARCH (2010)
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Mikko Taipale et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Clusterin as a Diagnostic and Prognostic Marker for Transitional Cell Carcinoma of the Bladder
Sahar M. Hazzaa et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin
Mototsugu Muramaki et al.
BJU INTERNATIONAL (2009)
Heat Shock Protein-27, -60 and -90 expression in gastric cancer: association with clinicopathological variables and patient survival
Constantinos Giaginis et al.
BMC GASTROENTEROLOGY (2009)
Heat shock protein inhibitors and vaccines as new agents in cancer treatment
Eleni M. Karapanagiotou et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
The expression pattern of the 70-kDa heat shock protein Hspa2 in mouse tissues
Natalia Vydra et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2009)
Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancer
Yoshiyuki Matsui et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer
Boris A. Hadaschik et al.
BJU INTERNATIONAL (2008)
Development and application of Hsp90 inhibitors
David B. Solit et al.
DRUG DISCOVERY TODAY (2008)
Heat shock proteins: Stress proteins with Janus-like properties in cancer
Stuart K. Calderwood et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2008)
HSP90 as a marker of progression in melanoma
M. M. McCarthy et al.
ANNALS OF ONCOLOGY (2008)
Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer
Anna Rodina et al.
NATURE CHEMICAL BIOLOGY (2007)
High HSP90 expression is associated with decreased survival in breast cancer
Elah Pick et al.
CANCER RESEARCH (2007)
Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes protein-remodeling activity
Shannon M. Doyle et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
HSP90 expression: A new predictive factor for BCG response in stage Ta-T1 grade 3 bladder tumours
Thierry Lebret et al.
EUROPEAN UROLOGY (2007)
Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells
Masayuki Kamada et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors
Marissa V. Powers et al.
ENDOCRINE-RELATED CANCER (2006)
Mechanisms of Disease: the role of heat-shock protein 90 in genitourinary malignancy
Jean-Baptiste Lattouf et al.
NATURE CLINICAL PRACTICE UROLOGY (2006)
Heat shock proteins in cancer: chaperones of tumorigenesis
SK Calderwood et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis
KH Sheng et al.
PROTEOMICS (2006)
Cytokeratin-20 and seminal vesicle secretory protein VI as possible marker proteins in urinary bladder preneoplastic lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine
HJ Kim et al.
INTERNATIONAL JOURNAL OF UROLOGY (2006)
Tumor selectivity of Hsp90 inhibitors: The explanation remains elusive
Gabriela Chiosis et al.
ACS CHEMICAL BIOLOGY (2006)
Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis
P Rocchi et al.
CANCER RESEARCH (2005)
Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia
X Thomas et al.
LEUKEMIA RESEARCH (2005)
Protein quality control: chaperones culling corrupt conformations
AJ McClellan et al.
NATURE CELL BIOLOGY (2005)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
Hsp70 chaperones: Cellular functions and molecular mechanism
MP Mayer et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer
M Gleave et al.
WORLD JOURNAL OF UROLOGY (2005)
Antisense oligonucleotide therapy in the management of bladder cancer
A So et al.
CURRENT OPINION IN UROLOGY (2005)
Enhanced chemosensitivity of bladder cancer cells to cisplatin by suppression of clusterin in vitro
J Chung et al.
CANCER LETTERS (2004)
Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer
P Rocchi et al.
CANCER RESEARCH (2004)
Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer KoTCC-1cells
H Miyake et al.
JOURNAL OF UROLOGY (2004)
Small heat-shock proteins and clusterin: Intra- and extracellular molecular chaperones with a common mechanism of action and function?
JA Carver et al.
IUBMB LIFE (2003)
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
A Kamal et al.
NATURE (2003)
Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience
R Colombo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
Clinical significance of heat shock protein-70 expression in bladder cancer
KN Syrigos et al.
UROLOGY (2003)
Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function
AD Basso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer
HS Kassem et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Heat-shock protein 90, a chaperone for folding and regulation
D Picard
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Roles of heat-shock proteins in antigen presentation and cross-presentation
ZH Li et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Overexpression of clusterin in transitional cell carcinoma of the bladder is related to disease progression and recurrence
H Miyake et al.
UROLOGY (2002)
Stress-related gene expression in mice treated with inorganic arsenicals
J Liu et al.
TOXICOLOGICAL SCIENCES (2001)
Bladder cancer I.: Molecular and genetic basis of carcinogenesis
S Brandau et al.
EUROPEAN UROLOGY (2001)
Share Paper
